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ABSTRACT: Artificial metalloenzymes result from anchoring an active catalyst within a protein environment. Towards this goal, 
various localization strategies have been pursued: covalent-, supramolecular- or dative anchoring. Herein we show that introduction 
of a suitably positioned histidine residue contributes to firmly anchor via a dative bond a biotinylated rhodium pianostool complex 
within streptavidin. The in-silico design of the artificial metalloenzyme was confirmed by X-ray crystallography. The resulting 
artificial metalloenzyme displays significantly improved catalytic performance, both in terms of activity and selectivity in the trans-
fer hydrogenation of imines. Depending on the position of the histidine residue, both enantiomers of the salsolidine product can be 
obtained. 
INTRODUCTION 
In recent years, the field of artificial metalloenzymes has at-
tracted increasing attention as alternative to the more tradi-
tional heterogeneous-, homogeneous- and enzymatic cata-
lysts.1-6 Artificial metalloenzymes result from incorporation of 
a catalytically competent organometallic moiety within a 
protein scaffold. Towards this goal, covalent-, dative- and 
supramolecular anchoring strategies have been pursued. 
We and others have been relying on the biotin-(strept)avidin 
technology to create artificial metalloenzymes.7-11 The catalyt-
ic performance of these can be optimized relying on either 
chemical or genetic means.12 Recent structural and kinetic data 
of artificial metalloenzymes based on the biotin-streptavidin 
technology highlighted that: i) the metal is located in a shallow 
energy minimum resulting in poorly localized metal moieties 
(as reflected by low occupancy in the X-ray structure); ii) the 
presence of second coordination sphere provided by streptavi-
din significantly influences the selectivity of the resulting 
artificial metalloenzymes.13 In contrast, the activity (TOF, 
TON) is only moderately affected upon incorporation in strep-
tavidin. This presents a serious limitation towards the imple-
mentation of directed evolution protocols of artificial metal-
loenzymes. Indeed, it requires the precise quantification of the 
protein as any non-protein bound metal would lead to an ero-
sion of enantioselectivity.10 We speculated that, in addition to 
the biotin anchor, a properly positioned histidine residue pro-
vided by streptavidin may contribute to firmly localize the 
metal-containing biotinylated cofactor and to activate the 
precatalyst (Scheme 1). The groups of Lu and Watanabe inde-
pendently pioneered an anchoring strategy to introduce Schiff-
base complexes within apo-myoglobin. In both strategies, the 
Schiff-base complex was anchored thanks to a dative bond 
with the proximal histidine 93.14,15 In addition, Lu and 
coworkers introduced two cysteine residues that further con-
tributed to firmly localize the artificial cofactor thanks to the 
formation of two disulfide bonds with the Schiff-base.14 Com-
pared to the artificial metalloenzyme lacking the disulfide 
bridges, the dually anchored artificial metalloenzymes dis-
played improved sulfoxidase activity.14 Inspired by this ele-
gant study, we present our efforts towards the design and 
application of a dually anchored (i.e. dative and supramolecu-
lar) artificial metalloenzyme for the reduction of prochiral 
imines. 
RESULTS AND DISCUSSION 
Design considerations. With the aim of generating a widely 
applicable d6-pianostool complex for a variety of catalytic 
applications upon introduction in streptavidin (Sav hereafter), 
we set out to link the biotin anchor to the cyclopentadienyl 
moiety. This strategy leaves three coordination sites available 
for catalysis and/or activation via additional ligands (Scheme 
1). In order to gain a semi-quantitative insight on the position 
of the biotinylated pianostool complex 5 upon incorporation 
within Sav and which amino acid position may be amenable to 
bind to the metal upon mutation to a histidine, docking simula-
tions were performed. All X-ray crystal structures containing a 
biotinylated metal complex obtained within the Ward group 
indicate that the position of the biotin moiety and the Cαs of 
the protein are essentially invariant, irrespective of the nature 
of the metal complex bound to biotin.13,16-18 Therefore, the 
DFT-optimized structure of the monomeric biotinylated com-
plex [η5-(Biot-2)RhCl2(H2O)] was manually positioned into 
WT Sav (PDB code 1MK5) by superimposing the biotin an-
chor of the complex to the native biotin present in the crystal 
structure. Simulations were performed in NAMD19 using the 
CHARMM27 force-field20 with parameters developed in our 
group21 or elsewhere22 (See SI for details).  
  
Scheme 1 Dual anchoring strategy to localize and activate 
a biotinylated pianostool catalyst precursor upon incorpora-
tion into streptavidin. 
The system was subsequently minimized for 1000 Conjugate 
Gradient steps, followed by a short molecular dynamics simu-
lation (Langevin NVT ensemble) of 500 ps. The structure in 
the final snapshot was minimized again for 1000 steps to yield 
the docked structure. Only the aquo complex [η5-(Biot-
2)RhCl2(H2O)] and atoms within 5 Å of the complex were 
allowed to relax during the simulation, the rest of the protein 
was kept frozen. The resulting structure is depicted in Figure 1 
a. With respect to the rhodium-center, the two closest lying Cß 
atoms are provided by S112 (5.62 Å) and K121 (6.09 Å of the 
adjacent monomer). Next, a histidine residue was introduced 
at either position S112 or K121. The rhodium-bound water 
was replaced by a bond to the Nε histidine and the procedure 
described above was applied yielding [(η5-Biot-2)RhCl2] 5 ⊂ 
S112H Sav and [(η5-Biot-2)RhCl2] 5 ⊂ K121H Sav (Figure 1 
b and 1 c respectively). 
 
(a)        (b)          (c) 
Figure 1 Docked structure of [η5-(Biot-2)RhCl2(H2O)] ⊂ 
WT Sav (a); [(η5-Biot-2)RhCl2] 5 ⊂ S112H Sav (b) and 
[(η5-Biot-2)RhCl2] 5 ⊂ K121H Sav (the His is provided by 
the adjacent Sav monomer of the homotetrameric struc-
ture)(c). The pianostool complex and streptavidin’s side-
chains at positions 112 and 121 are displayed as stick rep-
resentation, Sav as solvent accessible surface. 
These simulations thus suggest that an ethylene spacer be-
tween the Cp*- and the biotin moieties positions the metal 
center in an environment, suitable for additional dative an-
choring to a histidine side chain upon mutation of either 
S112H or K121H. Similar docking simulations were per-
formed for complexes bearing either a methylene- or a propyl-
ene spacer in the presence of WT Sav. In both cases however, 
inspection of the docked structure revealed a less propitious 
environment for dative anchoring to an amino acid side chain 
of streptavidin: For the methylene spacer, steric hindrance 
between the docked ligand and the protein are observed 
whereas the propylene spacer projects the metal out of the 
biotin-binding vestibule (See SI). 
Synthesis. Having identified a suitable spacer between the 
biotin anchor and the Cp* moiety, the corresponding d6-piano 
stool complexes were synthesized. For this purpose, tetra-
methylcyclopentenone 1 was used as starting material for the 
synthesis of the cyclopentadienyl precursor H-2 according to a 
slightly modified protocol of Teuben and coworkers.23 Reac-
tion with RhCl3·(H2O)n or with [Ir(COD)Cl]2, followed by an 
in-situ oxidation with HCl, yielded the dinuclear pianostool 
complexes [η5-(2)RhCl2]22+ 3 and [η5-(2)IrCl2]22+ 4, respective-
ly.24,25 Subsequent biotinylation using the pentafluoro-
phenylester of biotin, allowed the isolation of the analytically 
pure, dimeric, [η5-(Biot-2)RhCl2]2 52 and [η5-(Biot-2)IrCl2]2 62 
respectively (See SI for details). 
 
Scheme 2 Synthesis of biotinylated pianostool complexes 
(a) and asymmetric transfer hydrogenation conditions used 
towards the production of salsolidine 8 (b). 
Catalysis. As model reaction, we selected the asymmetric 
transfer hydrogenation (ATH) of the prochiral imine 7 using 
biotinylated dimeric catalyst precursors 52 and 62. This reac-
tion is frequently used as a benchmark as it offers a straight-
forward access to the alkaloid salsolidine 8 (Scheme 2b).26 
Selected results are collected in Table 1 and can be summa-
rized as follows: 
1) The iridium catalyst precursor [η5-(Biot-2)IrCl2]2 62 leads to 
higher conversions than the rhodium congener [η5-(Biot-
2)RhCl2]2 52. The same trend applies upon incorporation in 
WT Sav albeit with reduced conversions (Entries 1-4). These 
results are in agreement with the findings of Ogo and cowork-
ers by which [Cp*Ir(H2O)3]2+ is a significantly more active 
transfer hydrogenation catalyst than [Cp*Rh(H2O)3]2+.27  
2) The presence of a histidine residue at position S112 Sav has 
a dramatic effect on the activity and the selectivity of the 
ATH. Salsolidine 8 is produced in 95% conversion and 41% 
ee (S) using [η5-(Biot-2)RhCl2] 5 ⊂ S112H at 55 °C and pH 
6.5. The activity and the selectivity can be further improved 
upon lowering the pH to 5.0 (quantitative conversion with 1 
mol % catalyst 5 and 55% ee (S)) (Table 1, entries 5 and 6). In 
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 stark contrast, the presence of a histidine residue at position 
S112H has a detrimental effect on ATH with iridium (Table 1, 
entry 9). These results corroborate those of both Süss-Fink and 
Himeda whereby the transfer hydrogenase activity of 
[Cp*Rh(diimine)Cl]+ is reportedly higher than that of 
[Cp*Ir(diimine)Cl]+ (diimine = phenanthroline or 2,2’-
bipyridine respectively).28-29 
3) Introduction of other coordinating amino acids bearing soft 
donors (eg. cysteine or methionine, Table 1, entries 15 and 18) 
at position S112 affords salsolidine in high yield albeit low 
enantioselectivity. Again here, we speculate that the metal is 
activated by coordination to a suitably positioned soft amino 
acid residue. Docking of [η5-(Biot-2)RhCl2] 5 ⊂ S112M in-
deed suggests that dative anchoring is likely (See SI). 
4) Introduction of a histidine residue at position K121H Sav 
affords (R)-salsolidine 8 in up to 79% ee using the rhodium 
catalyst at 55 °C (Table 1, entries 10 and 11). Again here, rac-
8 is produced with the iridium catalyst in the presence of 
K121H. Lowering the temperature leads, for both S112H and 
K121H mutants and in the presence of the rhodium catalyst, to 
a decrease in enantioselectivity (Table 1, entries 7-8 and 12-
13). This suggests that the ΔG‡ term is dominated by the en-
tropy contribution ΔS‡. 
5) All point mutants tested devoid of a histidine at either posi-
tion S112 or K121 afforded nearly racemic salsolidine 8 (ee < 
20%) (Table 1, entries 15-19). Interestingly, the double mutant 
S112H-K121H Sav gave very low levels of enantioselectivity 
(Table 1 entry 20). We speculate that, in the presence of the 
double mutant, the biotinylated cofactor binds indiscriminate-
ly, and thus in equimolar amounts, to either of S112H- and 
K121H-histidines, thus resulting in the production of (rac)-8. 
6) Compared to [η5-(Biot-2)RhCl2] 5 ⊂ WT Sav, both histi-
dine bearing artificial metalloenzymes [η5-(Biot-2)RhCl2] 5 ⊂ 
S112H Sav and [η5-(Biot-2)RhCl2] 5 ⊂ K121H display in-
creased turnover frequencies: 1 hour-1 for the WT Sav com-
pared to 6 hour-1 for both S112H and K121H mutants. 
 
Table 1 Selected results for the asymmetric transfer hydrogenation of prochiral imine 7 catalyzed by artificial metalloen-
zymes. 
entry [(η5-Biot-L)MCl2]2 Sav isoform Temp (°C) pH M loading conv. (%) ee (%) 
1 Rh – 55 6.5a 2% 26 rac. 
2 Ir – 55 6.5a 2% 87 rac. 
3 Rh WT 55 6.5a 2% 18 rac. 
4 Ir WT 55 6.5a 2% 60 6 (S) 
5 Rh S112H 55 6.5a 2% 95 41 (S) 
6 Rh S112H 55 5.0b 1% quant. 55 (S) 
7 Rh S112H 25 5.0c 2% 85 52 (S) 
8 Rh S112H 5 5.0b 1% 5 45 (S) 
9 Ir S112H 55 6.5a 2% 27 11 (S) 
10 Rh K121H 55 6.5a 2% 95 50 (R) 
11 Rh K121H 55 5.0b 1% quant. 79 (R) 
12 Rh K121H 25 5.0c 2% 25 50 (R) 
13 Rh K121H 5 5.0b 1% 5 50 (R) 
14 Ir K121H 55 6.5a 2% 37 rac. 
15 Rh S112C 55 6.5a 2% 93 14 (S) 
16 Rh S112E 55 6.5a 2% 26 rac. 
17 Rh S112K 55 6.5a 2% 40 13 (S) 
18 Rh S112M 55 6.5a 2% 98 19 (R) 
19  Rh K121N 55 6.5a 2% 44 rac. 
20 Rh S112H-121H 55 6.5a 2% 40 9 (R) 
aThe reaction was carried out in a MOPS buffer at pH 6.5 using HCOONa as hydride source: 2 mol % monomeric biotinylated 
catalyst 5 or 6 (458 µM final metal concentration), 4 mol % biotin binding sites (916 µM final concentration) and substrate 7 (22.9 
mM final concentration, total reaction volume 200 µL) (See SI). 
bThe reaction was carried out in a MOPS buffer at pH 5.0 using HCOONa as hydride source: 1 mol % monomeric biotinylated 
catalyst 5 or 6 (458 µM final metal concentration), 2 mol % biotin binding sites (916 µM final concentration) and substrate 7 (45.8 
mM final concentration, total reaction volume 200 µL) (See SI). 
cThe reactions were carried out in a MOPS buffer at pH 5.0 using HCOONa as hydride source: 2 mol% monomeric biotinylated 
complex 5 (680 µM final metal concentration and 2.64 mol % biotin binding sites (corresponding to 916 µM biotin binding sites)  
and substrate 7 (34 mM final concentration, total reaction volume of 200 µL). 
 
 Structural Characterization. Next, X-ray crystal structure 
analyses were carried out with the most selective artificial 
metalloenzymes: [(η5-Biot-2)RhCl2] ⊂ S112H and [η5-(Biot-
2)RhCl2] ⊂ K121H. Crystals of apo-streptavidin mutants 
S112H and K112H were soaked at pH 6 with an excess of 
complex [η5-(Biot-2)RhCl2]2 52. The crystal structures of 5 ⊂ 
S112H and 5 ⊂ K121H could be solved to 2.4 Å and 1.8 Å 
resolution, respectively. Both structures contained strong 
electron density in the Fo-Fc map in the biotin-binding pocket 
and in the proximity of the histidine residue either at position 
H112 or H121. The monomeric complexes [η5-(Biot-2)Rh]2+ 
and [η5-(Biot-2)RhCl]+ were fitted into the electron densities 
localized around H112 and H121’ respectively (Figure 2 and 
SI Figure 3). As highlighted by the docking simulations, the 
H121’ of an adjacent monomer in homotetrameric streptavidin 
lies closest to the Rh in the 5 ⊂ K121H structure, Figure 1 c 
and 2b. Dative bonds were modeled between rhodium and the 
corresponding histidine: Rh–NδHis112 2.3 Å for 5 ⊂ S112H and 
Rh–NεHis121’ 2.3 Å for 5 ⊂ K121H. The Rh····Rh distances 
between two biotinylated molecules bound to neighboring 
symmetry-related Sav monomers are 9.5 Å and 9.2 Å for 5 ⊂ 
S112H and 5 ⊂ K121H, respectively. The position of the 
complexes in the S112H and K121H isoforms differs by an 
approximate 180° rotation of the Cp*Rh(Cl) group along an 
axis pointing towards the biotin binding pocket. Compared to 
the X-ray structure of biotin-loaded Sav (pdb code 1stp), the 
rmsd of the Cα for 5 ⊂ S112H and 5 ⊂ K121H are 0.247 Å 
and 0.214 Å respectively, highlighting the minimal structural 
reorganization of the host protein upon introduction of he 
biotinylated cofactor. 
For the complex bound to S112H, no additional electron den-
sity to complete the three-legged pianostool geometry could be 
detected whereas the presence of a chloride ligand was appar-
ent for the K121H structure. 
    
a)         b) 
Figure 2 Close-up view of the X-ray crystal structure of 
[(η5-Biot-2)Rh]2+ ⊂ S112H Sav (a); and [(η5-Biot-2)RhCl]+ ⊂ K121H Sav (b). The protein is displayed as surface rep-
resentation and the ligand molecules as well as residues 
112 and 121 in stick representation. The positions of ligand 
molecules are indicated by the 2Fo-Fc electron density 
(blue, contoured at 1.0 σ) and anomalous difference density 
(red, contoured at 4 σ, due to weak absorption at a wave-
length of 1.00 Å no anomalous density was observed in 
structure [(η5-Biot-2)RhCl]+ ⊂ K121H Sav). Rhodium is 
colored in orange and chlorine in green. Residues H121’ 
and K121’ are provided by the adjacent Sav monomer. 
Comparison of the docked vs. X-ray structures of both mutant 
metalloenzymes reveals a semi-quantitative agreement: the 
computed rmsd = 3.4 Å for the pianostool atoms in 5 ⊂ S112H 
and 2.1 Å for the pianostool atoms in 5 ⊂ K121H. Upon an-
choring the catalyst via Rh–NδHis112, as found in the X-ray 
structure (Figure 2a), the rmsd decreases to 1.23 Å (See SI). 
These deviations can by-and-large be traced back to the differ-
ing conformation adopted by the ethylene spacer (docked vs. 
X-ray, See SI). Despite this, the docking proved predictive 
enough to successfully engineer dative anchoring sites for the 
biotinylated cofactor. A full parametrization of the biotinylat-
ed Rh-pianostool moiety will be required to yield more relia-
ble docking results. 
Inspection of the steric environment enforced by the host 
protein around the [(η5-Biot-2)RhCl2] ⊂ S112H and [η5-(Biot-
2)RhCl2] ⊂ K121H reveals a “pseudo-mirror image relation-
ship” between the two mutant artificial metalloenzymes, thus 
accounting for the production of (S)-8 and (R)-8  respectively 
(Figure 3 a and b).  
 
 
Figure 3 Schematic representation of [(η5-Biot-2)RhCl2] ⊂ 
K121H Sav (a); and [(η5-Biot-2)RhCl2] ⊂ S112H Sav (b). 
The steric bulk provided by Sav creates “pseudo mirror-
image environments” around the two transfer hydrogenas-
es, thus favouring the approach of opposite prochiral faces 
of the imine substrate (in yellow). 
 
OUTLOOK 
Dual anchoring of a biotinylated three-legged rhodium pianos-
tool complex affords an artificial transfer hydrogenase. It was 
shown that coordination of the catalyst precursor to a suitably 
positioned histidine residue has a significant impact on the 
catalyst’s performance, both in terms of activity and of selec-
tivity. The computational design towards the identification of 
the spacer-length and site of mutation was confirmed by X-ray 
crystallography for the most selective artificial metalloen-
zymes [η5-(Biot-2)RhCl2] 5 ⊂ K121H and [η5-(Biot-2)RhCl2] 
5 ⊂ S112H. Current efforts are aimed at computing the transi-
tion state to identify and engineer additional second coordina-
tion sphere interactions to improve the catalytic performance 
of these dually-anchored artificial metalloenzymes. 
Supporting Information. Modelling, biotinylated complex syn-
thesis and characterization, catalytic runs and X-ray data. This 
material is available free of charge via the Internet at 
http://pubs.acs.org. 
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